To the best of our knowledge, this is the first original study to comprehensively evaluate CA 15-3, CEA, and CA 125 tumor markers as predictors of [18F]NaF PET positivity while adjusting for routine clinical covariates (age, ALP, and LDH). The gene discussed is CEACAM5; the disease is neoplasm.